Search results
Results from the WOW.Com Content Network
Crews working at the site of the deadliest aviation disaster in a generation have recovered all 67 victims of the collision between two aircraft over the Potomac River in Washington, DC, officials ...
The National Transportation Safety Board (NTSB) is set to provide an update Saturday on the investigation into the recent aircraft collision outside of Reagan Washington National Airport. More ...
An American Airlines jet and an Army helicopter collided over Washington, D.C., Wednesday night. All 67 people aboard the aircraft are presumed dead.
Because of AAV's specialized gene therapy advantages, researchers have created an altered version of AAV termed self-complementary adeno-associated virus (scAAV). Whereas AAV packages a single strand of DNA and must wait for its second strand to be synthesized, scAAV packages two shorter strands that are complementary to each other.
A 2021 U.S. Centers for Disease Control and Prevention poster on the COVID-19 viral vector vaccines. Viral vectors are modified viruses designed to deliver genetic material into cells. This process can be performed inside an organism or in cell culture. Viral vectors have widespread applications in basic research, agriculture, and medicine.
Recombinant adeno-associated virus (rAAV) based genome engineering is a genome editing platform centered on the use of recombinant AAV vectors that enables insertion, deletion or substitution of DNA sequences into the genomes of live mammalian cells.
The NTSB, alongside the FAA and other federal and local agencies, are investigating the crash. The NTSB briefing is expected to begin at 2:45 p.m. EST. Watch the live video above.
Health Security Headlines, a news digest published 3 times a week [15] (previously called Biosecurity Briefing, [16] then Biosecurity News in Brief starting in 2009, [17] then Biosecurity News Today starting in 2010 or 2011, [18] and finally Health Security Headlines starting in 2013; [19] [20] the digest used to also be weekly until in ...